Starpharma (SPL.AX) Hitches Ride On Dow Deal 
10/19/2005 5:12:31 PM

Melbourne pharmaceutical developer Starpharma Holdings is on the verge of signing a strategic deal with Dow Chemical Company that would shore up its intellectual property position and give it access to an estimated 200 patents in the competitive field of nanotechnology.